Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP619186.RAjPRjrZleoclK7hD5fSlj8js11c5sMCrXzFemGY2WUeE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP619186.RAjPRjrZleoclK7hD5fSlj8js11c5sMCrXzFemGY2WUeE130_assertion type Assertion NP619186.RAjPRjrZleoclK7hD5fSlj8js11c5sMCrXzFemGY2WUeE130_head.
- NP619186.RAjPRjrZleoclK7hD5fSlj8js11c5sMCrXzFemGY2WUeE130_assertion description "[Furthermore, IL-15 pretreatment increased the ADCC up to 71 � 3% in IIB-BR-G and 79 � 3.5% in IIB-BR-G MT.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP619186.RAjPRjrZleoclK7hD5fSlj8js11c5sMCrXzFemGY2WUeE130_provenance.
- NP619186.RAjPRjrZleoclK7hD5fSlj8js11c5sMCrXzFemGY2WUeE130_assertion evidence source_evidence_literature NP619186.RAjPRjrZleoclK7hD5fSlj8js11c5sMCrXzFemGY2WUeE130_provenance.
- NP619186.RAjPRjrZleoclK7hD5fSlj8js11c5sMCrXzFemGY2WUeE130_assertion SIO_000772 21308409 NP619186.RAjPRjrZleoclK7hD5fSlj8js11c5sMCrXzFemGY2WUeE130_provenance.
- NP619186.RAjPRjrZleoclK7hD5fSlj8js11c5sMCrXzFemGY2WUeE130_assertion wasDerivedFrom befree-20140225 NP619186.RAjPRjrZleoclK7hD5fSlj8js11c5sMCrXzFemGY2WUeE130_provenance.
- NP619186.RAjPRjrZleoclK7hD5fSlj8js11c5sMCrXzFemGY2WUeE130_assertion wasGeneratedBy ECO_0000203 NP619186.RAjPRjrZleoclK7hD5fSlj8js11c5sMCrXzFemGY2WUeE130_provenance.